These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10965964)

  • 21. Prevention of hepatitis B recurrence after liver transplantation using lamivudine and hepatitis B immune globulin.
    Ołdakowska-Jedynak U; Paczek L; Foroncewicz B; Mucha K; Nyckowski P; Zieniewicz K; Ziarkiewicz-Wróblewska B; Ziółkowski J; Pilecki T; Patkowski W; Górnicka B; Paczkowska A; Krawczyk M
    Ann Transplant; 2007; 12(3):28-32. PubMed ID: 18290567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of hepatitis B recurrence with indefinite hepatitis B immune globulin (HBIG) prophylaxis after liver transplantation.
    Nymann T; Shokouh-Amiri MH; Vera SR; Riely CA; Alloway RR; Gaber AO
    Clin Transplant; 1996 Dec; 10(6 Pt 2):663-7. PubMed ID: 8996762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B immune globulin: the US experience.
    Pruett TL; McGory R
    Clin Transplant; 2000; 14 Suppl 2():7-13. PubMed ID: 10965958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
    Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
    Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term high-dose followed by long-term low-dose hepatitis B immunoglobulin and lamivudine therapy prevented recurrent hepatitis B after liver transplantation.
    Takaki A; Yagi T; Iwasaki Y; Sadamori H; Matsukawa H; Matsuda H; Shinoura S; Umeda Y; Miyake Y; Terada R; Kobashi H; Sakaguchi K; Tanaka N; Shiratori Y
    Transplantation; 2007 Jan; 83(2):231-3. PubMed ID: 17264822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleoside plus nucleotide analogs and cessation of hepatitis B immunoglobulin after liver transplantation in chronic hepatitis B is safe and effective.
    Wesdorp DJ; Knoester M; Braat AE; Coenraad MJ; Vossen AC; Claas EC; van Hoek B
    J Clin Virol; 2013 Sep; 58(1):67-73. PubMed ID: 23880162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allografts positive for hepatitis B surface antigen in liver transplant for disease related to hepatitis B virus.
    Ju W; Chen M; Guo Z; Wang D; Zhu X; Huang J; He X
    Exp Clin Transplant; 2013 Jun; 11(3):245-9. PubMed ID: 23176583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Experiences with liver transplantation in hepatitis B antigen positive liver cirrhosis].
    Steininger R; Mühlbacher F; Längle F; Gnant M; Sautner T; Götzinger P; Walgram M; Penner E; Radaszkiewicz T
    Wien Klin Wochenschr; 1991; 103(19):573-6. PubMed ID: 1759457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
    Lu MQ; Cai CJ; Zhao H; Yang Y; Chen GH
    Zhonghua Wai Ke Za Zhi; 2006 Jun; 44(11):742-4. PubMed ID: 16836920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Living donor liver transplantation for hepatitis B associated liver diseases: a 10-year experience in a single center.
    Ikegami T; Soejima Y; Ohta R; Taketomi A; Yoshizumi T; Harada N; Kayashima H; Maehara Y
    Hepatogastroenterology; 2008; 55(85):1445-9. PubMed ID: 18795708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B recurrence after liver transplantation: a single center experiences and review the literature.
    Dehghani SM; Taghavi SA; Geramizadeh B; Nikeghbalian S; Derakhshan N; Malekpour A; Malek-Hosseini SA
    Hepat Mon; 2013 Jan; 13(1):e6609. PubMed ID: 23483668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unusually rapid development of a HBsAG-positive liver cirrhosis after liver transplantation.
    Lautz HU; Müller R; Wittekind C; Mauz S; Barg-Hock H; Ringe B; Pichlmayr R; Schmidt FW
    Klin Wochenschr; 1989 Oct; 67(20):1061-5. PubMed ID: 2555627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of antiviral therapy on the natural history of hepatitis B virus recurrence after liver transplantation: retrospective study of 14 cases.
    Vizuete SG; Encinas JL; Prados E; Haro J; Cuervas-Mons V
    Transplant Proc; 1999 Sep; 31(6):2461-3. PubMed ID: 10500671
    [No Abstract]   [Full Text] [Related]  

  • 36. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver.
    de Jongh FE; Janssen HL; de Man RA; Hop WC; Schalm SW; van Blankenstein M
    Gastroenterology; 1992 Nov; 103(5):1630-5. PubMed ID: 1426884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decompensated hepatitis B virus-related cirrhosis successfully treated with lamivudine allowing surgery for hepatocellular carcinoma.
    Nakanishi S; Michitaka K; Miyake T; Hidaka S; Yoshino I; Konishi I; Iuchi H; Horiike N; Onji M
    Intern Med; 2003 May; 42(5):416-20. PubMed ID: 12793712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 6-month mixed-effect pharmacokinetic model for post-transplant intravenous anti-hepatitis B immunoglobulin prophylaxis.
    Han S; Na GH; Kim DG
    Drug Des Devel Ther; 2017; 11():2099-2107. PubMed ID: 28744101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HBV prophylaxis: cost/benefit analysis following liver transplantation for HBV-positive liver cirrhosis.
    Golling M; Arnold JC; Rudek B; Mehrabi A; Kraus T; Herfarth C; Klar E
    Transplant Proc; 1998 Nov; 30(7):3316-7. PubMed ID: 9838466
    [No Abstract]   [Full Text] [Related]  

  • 40. Protective hepatitis B surface antibodies in blood and ascites fluid in the early stage after liver transplantation for hepatitis B diseases.
    Wang K; Zhu ZJ; Zheng H; Deng YL; Pan C; Sun LY; Shen ZY
    Hepatol Res; 2012 Mar; 42(3):280-7. PubMed ID: 22176205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.